Solasta Ventures — Full Portfolio

Kymera is a clinical-stage biotechnology company developing novel medicines using targeted protein degradation technology to treat diseases caused by previously "undrugged" proteins.

BiotechDeep TechHealthtech

NMNello Mainolfi(Founder)inBBBruce Booth(Chair)in

Co-investorsATAtlas VentureAVAvoro Capital AdvisorsBABain Capital Life SciencesBEBessemer Venture PartnersHAHatteras Venture PartnersMRMRL Ventures Fund+5 more

Pinterest operates a visual discovery platform where users save and browse images organised into boards, used heavily for shopping, recipes and design.

San Francisco, US

ESEvan Sharp(Co-founder & CDO)BSBen Silbermann(Co-founder & CEO)inPSPaul Sciarra(Co-founder)Mike Yang(Executive Officer)Natalie Fair(Executive Officer)BRBill Readyin

Co-investorsA.A.Capital VenturesA*A*ACAcequia Capital (AceCap)ALAllied Venture PartnersAMAmakorANAndreessen Horowitz+52 more

Rallybio is a clinical-stage biotech company developing therapies for people with severe and rare diseases, with a pipeline focused on complement dysregulation and hematology.

BiotechHealthtechNew Haven, US

SUStephen Uden(Founder)inMWMartin W. Mackay(Chairman of the Board of Directors)inJon(Chief Financial Officer)

Co-investors5A5AM VenturesCACanaan PartnersCOConnecticut InnovationsF-F-Prime CapitalMIMitsui Global InvestmentPIPivotal Life Sciences

Seer develops proteomics tools for large-scale protein analysis, including an assay, automation instrument, and analysis software for studying the proteome across human and non-human samples.

BiotechDeep TechHardwareHealthtech

OFOmid Farokhzad(Chair and Chief Executive Officer)in

Co-investorsSOSoftBank Vision FundWIWingAMaMoonMAMaverick VenturesT.T. Rowe Price

Sutro is a biotech company developing a cell-free protein synthesis platform for the design and manufacturing of complex biologics, particularly cancer therapies and antibody-drug conjugates.

BiotechDeep TechHealthtechMedical DevicesSouth San Francisco, US

William J. Newell(Executive Officer, Director)JCJane Chung(Chief Executive Officer)inHGHans-Peter Gerber(Chief Scientific Officer)inDPDavid Pauling(Chief Administrative Officer and General Counsel)inJFJonathan Fawcett(VP, Head of Clinical Development)inDevendra Luhar(SVP, Technical Operations)in

Co-investorsOWOwl CapitalSASamsara BioCapitalSVSV Health InvestorsVIVida Ventures

Synlogic develops synthetic biology-based biotherapeutics that use engineered living organisms to treat diseases.

BiotechDeep TechMedical DevicesCambridge, US

BCBharatt Chowrira(Executive Officer)inMSMichael Sheahan(Executive Officer)Jose Carlos Gutierrez-Ramos(Executive Officer, Director)inPMPaul Miller(Executive Officer)inABAoife Brennan(Executive Officer)inTSTodd Shegog(Executive Officer)in

Co-investorsATAtlas VentureNENew Enterprise Associates (NEA)NSNSG VenturesPFPfizer Venture InvestmentsSOSofinnova VenturesOROrbiMed

Xilio Therapeutics is a clinical-stage biotechnology company developing masked immuno-oncology therapies that use protein engineering to remain inactive until activated by tumor-specific proteases within the tumor microenvironment.

BiotechHealthtechWaltham, US

RRRené Russo(Executive Officer, Director)inJoseph Farmer(Executive Officer)Timothy Clackson(Executive Officer)Christopher Frankenfield(Chief Financial and Operating Officer)inKLKatarina Luptakova(Chief Medical Officer)inPaul Clancy(Director)

Co-investorsBABain Capital Life SciencesBABay City CapitalF-F-Prime CapitalM M VenturesMRMRL Ventures FundRARA Capital+9 more

Trefoil Therapeutics is a clinical-stage biotechnology company developing therapeutic agents for corneal diseases.

BiotechHealthtechMedical DevicesSan Diego, US

DEDavid Eveleth(Executive Officer, Director)inSNSchalon Newton(Executive Officer)in

BoardCSChristy Shaffer(Director)inRalph Bradshaw(Director)

Co-investorsEXExSight VenturesHAHatteras Venture PartnersACAccess BiotechnologyBIBios PartnersCOCorrelation VenturesFEFemHealth Ventures+2 more

EvolveImmune develops immunotherapy treatments for cancer patients.

BiotechHealthtechMedical Devices

Stephen Bloch(Co-founder and Chief Executive Officer)Jay Fine(President, Research and Development)

Co-investorsPFPfizer VenturesPFPfizer Venture Investments

Co-investorsAVAvoro Capital AdvisorsEPEpidarex CapitalF-F-Prime CapitalKEKeyhorse CapitalSOSofinnova VenturesVEvenBio Partners

Arcellx develops CAR T-cell therapies that are individually designed for each patient, using the immune system to target and attack cancer.

BiotechHealthtechGaithersburg, US

Han Lee(Executive Officer)RERami Elghandour(Executive Officer, Director)in

BoardJCJill Carroll(Director)inABAli Behbahani(Director)inDYDerek Yoon(Director)inTATiba Aynechi(Director)in

Co-investorsLGLG Technology VenturesNENew Enterprise Associates (NEA)QUQuan CapitalSASamsara BioCapitalSISixty Degree CapitalSRSR One Capital Management+5 more

Axonis Therapeutics is a biotechnology company developing small-molecule medicines that target KCC2, a mediator of inhibition in the brain, to treat neurological disorders such as epilepsy and pain.

BiotechDeep TechBoston, US

SVShane V. Hegarty(Chief Scientific Officer & Co-Founder)inJSJoanna Stanicka(Chief Executive Officer, President & Co-Founder)inJIJeff Imbaro(Chief Operating Officer)inTSTiasha Shafiq(Chief of Staff)in

BoardCorey . Goodman(Director)inJLJonathan Leff(Director)in

Co-investorsVEvenBio PartnersMRMRL Ventures FundSOSofinnova VenturesCICivilization Ventures Management, LlcCRCreative Destruction Lab (CDL)HAHatteras Venture Partners+7 more

Boxhub operates an online marketplace for buying and selling shipping containers, modernizing the traditionally fragmented container trade through digital technology.

B2B MarketplacesE-commerceLogistics & Supply Chain

MBMaxmillian Birner(Co-Founder & CEO)MBMaximilian Birner(Founder)in

Co-investorsALAlleyCorpALAlley Robotics VenturesFJFJ LabsHUHum CapitalINInterplay Ventures Early Stage Management LlcMOMotion Ventures

The page presents Pinco Casino, an online gambling platform offering slots, live casino, table games, and sports betting with a Turkish-language interface.

ConsumerGamingHealthtechBoston, US

Robert Kotin(Executive Officer, Director)Chen Schor(Director)Robert Hadfield(Executive Officer)John Lawrence(Executive Officer)

BoardGVGeeta Vemuri(Director)inDYDerek Yoon(Director)in

Co-investorsASAstellas Venture Management LLCDCDC Investment PartnersUTUTokyo Innovation Platform Co. Ltd.AGAgent CapitalLOLongwood Fund

CAR-Macrophage cellular therapeutics with initial oncology focus (NASDAQ: CARM).

BiotechPhiladelphia, US

SKSteven Kelly(Executive Officer, Director)in

BoardMargarita Chavez(Director)inEran Nadav(Director)Althea Stillman(Director)Jacob Gunterberg(Director)RHRegina Hodits(Director)in

Co-investorsAGAgent CapitalAJAju IB Invesment CorporationANAnzu PartnersGRGrazia Equity GmbHHEHealthCapMRMRL Ventures Fund+1 more

BiotechBerkeley, US

GWGenine Winslow(Founder)inRan Geng(Director)Winnie Wan(Director)

Co-investorsBEBerkeley SkyDeck FundFUFuture Planet CapitalTATachyon Ventures

Clearside Biomedical is an intellectual property holding, investment, and commercialization company focused on its suprachoroidal space (SCS) ocular drug-delivery platform and microinjector technology.

BiotechHealthtechMedical DevicesAlpharetta, US

Mark Prausnitz(Director)inCharles Deignan(Executive Officer)GNGlenn Noronha(Executive Officer)inDaniel H. White(Executive Officer, Director)in

BoardEvgeny Zaytsev(Director)DYDerek Yoon(Director)in

Co-investorsHEHEALTHCARE ROYALTY PARTNERSMOMountain Group CapitalHAHatterasHAHatteras Venture Partners

Ensoma is a genomic medicine company developing a platform for in vivo engineering of hematopoietic stem cells (HSCs), combining an off-the-shelf delivery system with a gene engineering toolkit intended to treat diseases with a one-time treatment.

BiotechHealthtechMedical DevicesBoston, US

Albert Seymour(Director)

BoardKPKush Parmar(Executive Officer, Director)inPSPaula Soteropoulos(Director)SKStephen Knight(Director)in

Co-investors5A5AM VenturesAJAju IB Invesment CorporationCACatalio Capital Management, LPDEDelos CapitalF-F-Prime CapitalALAlexandria+7 more

G1 Therapeutics develops cancer therapies focused on improving patient outcomes and quality of life for people with cancer.

BiotechResearch Triangle Park, US

Jay Strum(Executive Officer)NSNorman Sharpless(Director)Mark A. Velleca(Executive Officer, Director)inThomas K Laundon(Executive Officer)Timothy Sullivan(Director)Gregory Mossinghoff(Executive Officer)

Co-investorsLULumira VenturesMOMountain Group CapitalRARA CapitalHAHatteras Venture Partners

HotSpot Therapeutics develops novel biopharmaceutical products and therapeutic platforms focused on innovative biomedical technologies.

AI & Machine LearningBiotechHealthtech

BoardBBBruce Booth(Chairman)in

Co-investorsATAtlas VentureB B Capital GroupB4B4 CapitalMRMRL Ventures FundSOSofinnova PartnersSRSR One Capital Management+1 more

Immunitas discovers and develops therapeutic antibodies for cancer and autoimmune diseases, with its lead program targeting CD161 for solid tumors and hematological malignancies.

BiotechDigital HealthMedical DevicesWaltham, US

Amanda Wagner(Executive Officer)Dan Matloff(Executive Officer)Jiaping Gu(Director)Jeffrey Goldberg(Executive Officer, Director)

BoardLBLaura Brass(Director)inKWKai Wucherpfennig(Director)

Co-investorsAGAgent CapitalDCDC Investment PartnersLOLongwood FundMEMedical Excellence CapitalNONovartis Venture FundONOno Venture Investment, Inc.+3 more

Kezar Life Sciences is a clinical-stage biotechnology company developing small-molecule therapeutics for immune-mediated diseases and cancer.

BiotechSouth San Francisco, US

JFJohn F. Fowler(Executive Officer, Director)inChristopher J. Kirk(Executive Officer, Director)

BoardDr. Gerald Chan(Director)Dr. Jean-Pierre Sommadossi(Director)

Co-investorsBABay City CapitalCHChiesi VenturesPAPappas CapitalECEcoR1 CapitalQIQiming Venture Partners

Maxion Therapeutics develops protein and antibody therapeutics using its patented KnotBody technology, which fuses cysteine-rich miniproteins (Knottins) into antibody binding loops to target ion channels and GPCRs.

BiotechHealthtechCambridge, GB

JMJohn McCafferty(Co-founder and CTO)inAneesh Karatt-Vellatt(Co-founder and CSO)in

Co-investorsLILifeArc VenturesMOMonograph Capital PartnersGEGeneral Catalyst

Molecular Templates, Inc. was a clinical-stage biopharmaceutical company formerly based in Austin, TX.

BiotechAustin, US

Co-investorsLOLongitude CapitalSOSofinnova Ventures

Orionis Biosciences discovers and engineers molecules that connect proteins on or within cells to reprogram disease-driving processes or activate immune responses.

BiotechDeep TechNewton, US

Nikolai Kley(Founder)inNikolai Kley, Ph.D.(Executive Officer, Director)

BoardGriet Vanpoucke, Ph.D.(Director)Steven R. Gullans, Ph.D.(Director)

Co-investorsEXExcel Venture ManagementSOSolari CapitalV-V-Bio VenturesWEWessel Management

Prime Roots makes plant-based deli meats designed to match conventional meat in blind taste tests, using clean ingredients without nitrates or celery salt.

ConsumerFoodTech

KLKimberlie Le(Founder)in

Co-investorsDIDiamond Edge VenturesDNDnx VenturesPAPangaea Ventures Us Inc.POPortfoliaSPSpiral Sun VenturesALAlumni Ventures+7 more

RAPT Therapeutics is a clinical-stage biopharmaceutical company developing therapeutics that target the immune system to treat inflammatory and immunologic diseases.

BiotechHealthtech

Co-investorsFRFrazier Life SciencesKLKleiner PerkinsTHThe Column GroupOROrbiMed

ReCode develops mRNA and gene correction therapeutics for genetic diseases, using proprietary lipid nanoparticle technology to deliver treatments to specific organs.

AI & Machine LearningBiotechHealthtechMedical DevicesMenlo Park, US

Dr. Daniel J. SiegwartArthur E Johnson(Executive Officer, Director)

Co-investorsAJAju IB Invesment CorporationECEcoR1 CapitalEVEvolution VC PartnersMPMPM BioImpactOROrbiMedOUOUP (Osage University Partners)+6 more

Soul is a Chinese AI-powered immersive social platform where users interact through customizable avatars rather than real identities, matched by interest graphs and AI-driven recommendations.

AI & Machine LearningConsumerSocialShanghai, CN

Zhang Lu(CEO & Founder)Tao Ming(Chief Technology Officer & Executive Director)Zhang Gaozheng(Vice President of Technology & Executive Director)

Co-investorsGRGranite AsiaMOMorningside Venture Capital LimitedCLCleveland AvenueHOHorizons VenturesLILiberty City VenturesSASalesforce Ventures+1 more

Soul Machines develops "Experiential AI" technology to create lifelike, human-like Digital Workers that can see, hear, react, remember and respond emotionally, using cognitive modeling and a patented Digital Brain.

AI & Machine LearningDeep TechEnterprise SoftwareSaaS

GCGreg Cross(Co-Founder & CEO)MSMark Sagar(Co-Founder & CSO)Julie Kim(Chief Executive Officer)ARAli Roberts(Chief Financial Officer)inShane Blackett(Chief Technology Officer)inDarren Wilson(Chief Product Officer)

Co-investorsBRBright Pixel CapitalCLCleveland AvenueSOSoftBank Vision FundHOHorizons VenturesLALakestarLILiberty City Ventures+2 more

Summer Robotics builds laser-event sensing technology, a camera-free perception system that lets industrial robots recognize, track, measure, and adapt to parts in real time with 100-micron precision and fast reaction times.

Advanced ManufacturingHardwareRoboticsCampbell, US

Gerard Dirk Smits(Director)Schuyler Alexander Cullen(Executive Officer, Director)

Co-investorsAJAju IB Invesment CorporationAPApplied VenturesNANaver